A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 31/70 (2006.01) A61K 39/15 (2006.01) A61K 39/165 (2006.01) A61K 47/10 (2006.01) A61K 47/34 (2006.01) C12N 15/88 (2006.01)
Patent
CA 2236925
A microparticle contains DNA coding for a polypeptide and oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function.
L'invention se rapporte à une microparticule contenant de l'ADN codant pour un polypeptide et l'administration par voie orale de cette microparticule qui conduit à son expression. L'ADN codant pour un immunogène est destiné à stimuler la formation d'anticorps chez un receveur, et l'ADN codant pour un polypeptide non-immunogène est destiné à être appliqué en thérapie génique. L'ADN est introduit dans la microparticule sans destruction de sa fonction.
Clegg James Christopher Stephen
Farrar Graham Henry
Jones David Hugh
Goudreau Gage Dubuc
Microbiological Research Authority
LandOfFree
Microencapsulated dna for vaccination and gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microencapsulated dna for vaccination and gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microencapsulated dna for vaccination and gene therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1413693